Website profile

Pr Newswire

PR Newswire’s news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.

  • 5,996articles · 30d
  • 7+ hour agolatest article
  • Aug 14, 2026earliest in window
  • 92%with images
  • 272avg words
articles per day
Categories
  • Economy, Business & Finance 2,817
  • Finance & Business 2,246
  • News 1,506
  • Business & Industrial 789
  • Science & Technology 653
  • Health & Wellness 609
  • Medical 563
  • Arts, Culture, Entertainment & Media 529

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@PRNewswire
prnewswire.com > news-releases > iflex-stretch-studios-adds-kinotek-3d-movement-technology-to-every-experience-302874396.html

iFlex Stretch Studios Adds Kinotek® 3D Movement Technology to Every Experience

3+ day, 8+ hour ago   (256+ words) Sep 09, 2026, 19:11 ET Before a therapist begins a session, Kinotek's markerless 3D movement assessment captures a client's body in motion – no markers, sensors, or wearables required. In seconds, the technology analyzes range of motion, symmetry, and movement quality to provide deeper insights…...

@PRNewswire
prnewswire.com > news-releases > aft-pharmaceuticals-partners-with-mark-cuban-cost-plus-marketplace-to-bring-the-new-non-opioid-pain-medication-combogesic-to-the-us-302872553.html

AFT Pharmaceuticals partners with Mark Cuban Cost Plus Marketplace to bring the new non-opioid pain medication, Combogesic® to the U.S.

4+ day, 15+ hour ago   (253+ words) Sep 08, 2026, 12:16 ET That philosophy extends beyond the medicine itself. Through their partnership with the Mark Cuban Cost Plus Marketplace", AFT Pharmaceuticals is pairing pharmaceutical innovation with a world class pharmaceutical distribution model intended to improve patient health and making Combogesic…...

@PRNewswire
prnewswire.com > news-releases > sonex-health-announces-publication-of-largest-office-based-ultrasound-guided-carpal-tunnel-release-study-with-two-year-follow-up-302867276.html

SONEX HEALTH ANNOUNCES PUBLICATION OF LARGEST OFFICE-BASED ULTRASOUND-GUIDED CARPAL TUNNEL RELEASE STUDY WITH TWO-YEAR FOLLOW-UP

1+ week, 3+ day ago   (101+ words) Sep 02, 2026, 10:00 ET Data confirms office-based UGCTR as safe and effective option with patient-centered benefits of rapid improvement, fast return to activities and work, and durable improvements through two years without recurrences Key takeaways from patients treated with an office-based UGCTR…...

@PRNewswire
prnewswire.com > news-releases > professional-physical-therapy-launches-rise-program-to-help-physical-therapists-repay-student-loans-302866756.html

Professional Physical Therapy Launches RISE Program to Help Physical Therapists Repay Student Loans

1+ week, 4+ day ago   (353+ words) Sep 01, 2026, 15:32 ET New RISE Program will provide eligible participants with up to $50,000 in student loan repayment support MELVILLE, N.Y., Sept. 1, 2026 /PRNewswire/ -- Professional Physical Therapy today announced a new program designed to help current and future physical therapists overcome one of the…...

@PRNewswire
prnewswire.com > news-releases > 60-million-americans-live-with-chronic-pain-us-pain-foundation-launches-onevoiceforpain-302865794.html

60 Million Americans Live With Chronic Pain: U.S. Pain Foundation Launches #OneVoiceForPain

1+ week, 4+ day ago   (265+ words) Sep 01, 2026, 08:50 ET Pain Awareness Month campaign unites lived experience, data, and action to strengthen the collective voice of the pain community WEST HARTFORD, Conn., Sept. 1, 2026 /PRNewswire/ -- Chronic pain affects more than 60 million Americans. They span every age and countless diagnoses,…...

@PRNewswire
prnewswire.com > news-releases > vascarta-outlines-vas-101s-vasceptor-potential-as-a-non-opioid-advance-in-pain-medicine-across-sickle-cell-disease-osteoarthritis-and-cancer-302858963.html

Vascarta Outlines VAS-101's (Vasceptor®) Potential as a Non-Opioid Advance in Pain Medicine Across Sickle Cell Disease, Osteoarthritis, and Cancer

2+ week, 4+ day ago   (157+ words) Aug 25, 2026, 07:45 ET A Common Pathway Behind Very Different Pains Vasceptor is built on Vascarta's patented Vasporta™ gel-based delivery platform, which, combined with a small-molecule active pharmaceutical ingredient such as curcumin, is designed to cross the skin and reach plasma and…...

@PRNewswire
prnewswire.com > news-releases > joy-organics-expands-organic-thc-free-cbd-gummy-line-with-new-50mg-strength-and-sour-apple-flavor-302858997.html

Joy Organics Expands Organic THC-Free CBD Gummy Line With New 50mg Strength and Sour Apple Flavor

2+ week, 4+ day ago   (184+ words) Aug 25, 2026, 07:00 ET The new 50mg option delivers Joy Organics' highest-strength USDA-Certified Organic THC-free CBD gummy yet, now available in strawberry lemonade and new sour apple. FORT COLLINS, Colo., Aug. 25, 2026 /PRNewswire/ -- Joy Organics, a leading provider of premium hemp-derived wellness products, has…...

@PRNewswire
prnewswire.com > news-releases > pleopharma-awarded-6-5-million-nida-grant-to-support-phase-3-trial-of-pp-01-for-cannabis-withdrawal-in-patients-with-cannabis-use-disorder-302856379.html

PleoPharma Awarded $6.5 Million NIDA Grant to Support Phase 3 Trial of PP-01 for Cannabis Withdrawal in Patients with Cannabis Use Disorder

3+ week, 2+ day ago   (143+ words) Aug 20, 2026, 08:04 ET NIH/NIDA funding will support a pivotal clinical program for an investigational treatment for adults with cannabis use disorder These successful results have paved the way for CAN-004, the ongoing pivotal Phase 3 trial, with the first patient dosed…...

@PRNewswire
prnewswire.com > news-releases > keenova-advances-podiatry-pipeline-with-first-patient-dosed-in-phase-3-trial-of-xiaflex-collagenase-clostridium-histolyticum-for-hammer-toe-302855400.html

Keenova Advances Podiatry Pipeline with First Patient Dosed in Phase 3 Trial of XIAFLEX® (collagenase clostridium histolyticum) for Hammer Toe

3+ week, 2+ day ago   (231+ words) Aug 20, 2026, 07:30 ET DUBLIN, Aug. 20, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that the first patient has been successfully enrolled and received study treatment in its Phase 3 clinical trial evaluating XIAFLEX® (collagenase clostridium histolyticum) as an investigational nonsurgical treatment for patients with…...

@PRNewswire
prnewswire.com > news-releases > in-hellonation-physical-therapy-expert-dr-kali-spoto-larue-explains-how-physical-therapy-supports-back-and-neck-pain-relief-302855350.html

In HelloNation, Physical Therapy Expert Dr. Kali Spoto LaRue Explains How Physical Therapy Supports Back and Neck Pain Relief

3+ week, 3+ day ago   (203+ words) Aug 19, 2026, 10:16 ET The article explains how physical therapy improves mobility, flexibility, and movement patterns for long-term pain management. Posture education is another major focus discussed in the article. Prolonged and poor posture while sitting, driving, or using electronic devices can…...